Rowasa 4 g/60mL (Mesalamine SUSPENSION) 4 g/60mL

Rowasa 4 g/60mL is a rectal suspension containing mesalamine, used for managing inflammatory conditions. This medication is designed for targeted relief and is available in a convenient dispensing bottle.

Strength

4 g/60mL

Pack Size

28 BOTTLE, DISPENSING in 1 CARTON (0037-0066-03) / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06)

Manufacturer / TM Owner

Viatris Specialty LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rowasa 4 g/60mL is primarily used for the treatment of inflammatory conditions in the colon. Mesalamine, the active ingredient, helps to reduce inflammation in the rectum and colon. This medication is often prescribed for conditions that require localized treatment, such as what is mesalamine used for in managing rectal inflammation.

Side Effects

Common effects of Rowasa 4 g/60mL may include mild rectal discomfort or irritation. Some users might experience temporary changes in bowel movements. These effects are generally mild and may subside as the body adjusts to the medication.

Precautions & Warnings

Rowasa 4 g/60mL should be handled with care to avoid contamination. It is important to follow the prescribed administration instructions to ensure proper use. Always consult a healthcare provider before starting any new medication, especially if you have known allergies or sensitivities.

Avoid Interactions

Rowasa 4 g/60mL may interact with certain medications, including those that affect the immune system or other gastrointestinal treatments. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions.

References

Frequently Asked Questions

Rowasa 4 g/60mL is used for managing inflammatory conditions in the colon, providing targeted relief.

Rowasa 4 g/60mL is designed for rectal use. Follow the instructions provided by your healthcare provider for proper administration.

Common side effects may include mild rectal discomfort or irritation. These effects are usually temporary.

It is important to consult your healthcare provider before combining Rowasa 4 g/60mL with other medications to avoid potential interactions.

Long-term use of Rowasa 4 g/60mL should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.